Waltham, MA, United States of America

S Kirk Wright

USPTO Granted Patents = 9 


 

Average Co-Inventor Count = 8.5

ph-index = 4

Forward Citations = 47(Granted Patents)


Company Filing History:


Years Active: 2010-2015

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):

Title: **The Innovator Behind Hepatocyte Growth Factor Binding Proteins: S Kirk Wright**

Introduction

S Kirk Wright is a prominent inventor based in Waltham, MA, who has made significant contributions to the field of biotechnology. With a total of nine patents to his name, his work focuses primarily on breakthroughs involving hepatocyte growth factor and its related binding proteins. His innovations pave the way for new diagnostic and therapeutic approaches to treat disorders associated with HGF.

Latest Patents

Wright's latest patents revolve around the development of nucleic acid encoding hepatocyte growth factor (HGF) binding proteins. These groundbreaking inventions present a family of binding proteins designed to bind and neutralize the activity of human HGF. Their potential as diagnostic and therapeutic agents is noteworthy, as they may provide treatment options for various HGF responsive disorders, including certain tumors associated with HGF activity. The utility of these binding proteins positions them at the forefront of therapeutic innovation in the medical field.

Career Highlights

Throughout his career, S Kirk Wright has held significant positions in notable companies such as Aveo Pharmaceuticals, Inc. and Xoma Technology Ltd. His involvement in these organizations has enabled him to merge scientific research with practical applications, bringing innovative solutions to the marketplace and facilitating advancements in health technology.

Collaborations

Wright has also collaborated with esteemed professionals in the industry, including William M Winston, Jr. and May Han. These partnerships have fostered a collaborative environment that enhances the drive for research and development aimed at addressing compelling medical challenges.

Conclusion

S Kirk Wright continues to be a pivotal figure in the development of innovative therapies and diagnostic tools related to hepatocyte growth factor. His extensive patent portfolio, coupled with his collaborative work within the biotechnology sector, exemplifies his commitment to advancing scientific frontiers and improving patient outcomes in the realm of health care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…